Form 4 for SUPN SUPERNUS PHARMACEUTICALS, INC.
Accepted 2026-02-25 00:00:00 ET · period of report 2026-02-24 · accession 0001836067-26-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-02-25 | 2026-02-24 | SUPN | Rubin Jonathan | SVP, Chief Medical Off | F - Tax | $30.27 | -1,643 | 12.2K | -12% | -$49.7K |
| DM | 2026-02-25 | 2026-02-24 | SUPN | Rubin Jonathan | SVP, Chief Medical Off | A - Grant | $0.00 | +3,125 | 13.4K | +30% | $0 |
| DM | 2026-02-25 | 2026-02-24 | SUPN | Rubin Jonathan | SVP, Chief Medical Off | D - Sale to Iss | $0.00 | -3,125 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-24 | F | D | 603 | $51.35 | 11,806 | D | — | — | (F1) Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the RSU vesting. |
| 2 | Common | Common Stock | 2026-02-24 | A | A | 1,125 | $0.00 | 12,409 | D | — | — | |
| 3 | Common | Common Stock | 2026-02-24 | F | D | 671 | $0.00 | 12,766 | D | — | — | (F1) Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the RSU vesting. |
| 4 | Common | Common Stock | 2026-02-24 | A | A | 750 | $0.00 | 12,556 | D | — | — | |
| 5 | Common | Common Stock | 2026-02-24 | F | D | 369 | $50.86 | 12,187 | D | — | — | (F1) Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the RSU vesting. |
| 6 | Common | Common Stock | 2026-02-24 | A | A | 1,250 | $0.00 | 13,437 | D | — | — | |
| 7 | Derivative | Restricted Stock Unit | 2026-02-24 | D | D | 1,125 | $0.00 | 3,375 | D | — · — to — | 1,125 Common Stock | (F2) Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting. (F3) These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 19, 2026. |
| 8 | Derivative | Restricted Stock Unit | 2026-02-24 | D | D | 1,250 | $0.00 | 2,500 | D | — · — to — | 1,250 Common Stock | (F2) Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting. (F5) These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 22, 2025. |
| 9 | Derivative | Restricted Stock Unit | 2026-02-24 | D | D | 750 | $0.00 | 0 | D | — · — to — | 750 Common Stock | (F2) Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting. (F4) These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 22, 2023. |